
Overview
Availability
- Emeritus Professor Robert Tindle is:
- Available for supervision
- Media expert
Qualifications
- Bachelor (Honours) of Science (Advanced), Institution to be confirmed
- Doctor of Philosophy, University College London
Research impacts
The CD34 stem cell has replaced marrow transplation in the treatment of leukaemias and other diseases throughout the world.
The tolerogenic effect of the HPV 16 E7 oncoprotein informs the design of therapeutic vaccines for human cervical cancer.
Works
Search Professor Robert Tindle’s works on UQ eSpace
2004
Journal Article
Recombinant Kunjin virus replicon vaccines induce protective T-cell immunity against human papillomavirus 16 E7-expressing tumour
Herd, Karen A., Harvey, Tracey, Khromykh, Alexander A. and Tindle, Robert W. (2004). Recombinant Kunjin virus replicon vaccines induce protective T-cell immunity against human papillomavirus 16 E7-expressing tumour. Virology, 319 (2), 237-248. doi: 10.1016/j.virol.2003.10.032
2003
Journal Article
Enhanced effector and memory CTL responses generated by incorporation of receptor activator of NF-kappa B(RANK)/RANK ligand costimulatory molecules into dendritic cell immunogens expressing a human tumor-specific antigen
Wiethe, C., Dittmar, K., Doan, T., Lindenmaier, W. and Tindle, R. (2003). Enhanced effector and memory CTL responses generated by incorporation of receptor activator of NF-kappa B(RANK)/RANK ligand costimulatory molecules into dendritic cell immunogens expressing a human tumor-specific antigen. Journal of Immunology, 171 (8), 4121-4130. doi: 10.4049/jimmunol.171.8.4121
2003
Journal Article
Generation of CTL responses using Kunjin replicon RNA
Ward, Scott M., Tindle, Robert W., Khromykh, Alexander A. and Gowans, Eric J. (2003). Generation of CTL responses using Kunjin replicon RNA. Immunology And Cell Biology, 81 (1), 73-78. doi: 10.1046/j.0818-9641.2002.01137.x
2003
Journal Article
Provision of 4-1BB ligand enhances effector and memory CTL responses generated by immunization with dendritic cells expressing a human tumor-associated antigen
Wiethe, C, Dittmar, K, Doan, T, Lindenmaier, W and Tindle, R (2003). Provision of 4-1BB ligand enhances effector and memory CTL responses generated by immunization with dendritic cells expressing a human tumor-associated antigen. Journal of Immunology, 170 (6), 2912-2922. doi: 10.4049/jimmunol.170.6.2912
2003
Journal Article
Immunogenicity of recombinant HBsAg/HCV particles in mice pre-immunised with hepatitis B virus-specific vaccine
Netter, H.J., Woo, W.P., Tindle, R., Macfarlan, R.I. and Gowans, E.J. (2003). Immunogenicity of recombinant HBsAg/HCV particles in mice pre-immunised with hepatitis B virus-specific vaccine. Vaccine, 21 (21-22), 2692-2697. doi: 10.1016/S0264-410X(03)00182-8
2003
Journal Article
Paucity of functional CTL epitopes in the E7 oncoprotein of cervical cancer associated human papillomavirus type 16
Khammanivong, Vithagna, Liu, Xiao Song, Liu, Wen Jun, Rodda, Stuart J., Leggatt, Graham R., Tindle, Robert W., Frazer, Ian H. and Fernando, Germain J. P. (2003). Paucity of functional CTL epitopes in the E7 oncoprotein of cervical cancer associated human papillomavirus type 16. Immunology and Cell Biology, 81 (1), 1-7. doi: 10.1046/j.1440-1711.2003.01130.x
2002
Journal Article
Limitations of HLA-transgenic mice in presentation of HLA-restricted cytotoxic T-cell epitopes from endogenously processed human papillomavirus type 16 E7 protein
Street, MD, Doan, T, Herd, KA and Tindle, RW (2002). Limitations of HLA-transgenic mice in presentation of HLA-restricted cytotoxic T-cell epitopes from endogenously processed human papillomavirus type 16 E7 protein. Immunology, 106 (4), 526-536. doi: 10.1046/j.1365-2567.2002.01442.x
2002
Journal Article
Immune evasion in human papillomavirus-associated cervical cancer
Tindle, R. W. (2002). Immune evasion in human papillomavirus-associated cervical cancer. Nature Reviews Cancer, 2 (1), 59-65. doi: 10.1038/nrc700
2001
Journal Article
Nonspecific down-regulation of CD8+ T-Cell responses in mice expressing human Papillomavirus Type 16 E7 oncoprotein from the keratin-14 promoter
Tindle, Robert W., Herd, Karen A., Doan, Tracy, Bryson, Greg, Leggatt, Graham R., Lambert, Paul, Ian H. Frazer, and Street, Michael D. (2001). Nonspecific down-regulation of CD8+ T-Cell responses in mice expressing human Papillomavirus Type 16 E7 oncoprotein from the keratin-14 promoter. Journal of Virology, 75 (13), 5985-5997. doi: 10.1128/JVI.75.13.5985-5997.2001
2001
Journal Article
Antigenicity and immunogenicity of novel chimeric hepatitis B surface antigen particles with exposed hepatitis C virus epitopes
Netter, Hans J., MacNaughton, Thomas B., Woo, Wai-Ping, Tindle, Robert and Gowans, Eric J. (2001). Antigenicity and immunogenicity of novel chimeric hepatitis B surface antigen particles with exposed hepatitis C virus epitopes. Journal of Virology, 75 (5), 2130-2141. doi: 10.1128/JVI.75.5.2130-2141.2001
2001
Other Outputs
Subunit papilloma virus vaccine and peptides for use therein
Tindle, Robert, Fernando, Germain and Frazer, Ian (2001). Subunit papilloma virus vaccine and peptides for use therein. US6183745B1.
2001
Journal Article
Low level expression of human papillomavirus type 16 (HPV16) E6 in squamous epithelium does not elicit E6 specific B- or T-helper immunological responses, or influence the outcome of immunisation with E6 protein
Azoury-Ziadeh, R, Herd, K, Fernando, GJP, Lambert, P, Frazer, IH and Tindle, RW (2001). Low level expression of human papillomavirus type 16 (HPV16) E6 in squamous epithelium does not elicit E6 specific B- or T-helper immunological responses, or influence the outcome of immunisation with E6 protein. Virus Research, 73 (2), 189-199. doi: 10.1016/S0168-1702(00)00241-0
2001
Journal Article
Peripheral T-Cell tolerance defined through transgenic mouse studies
Tindle, RW (2001). Peripheral T-Cell tolerance defined through transgenic mouse studies. Autoimmunity, 33 (2), 135-149. doi: 10.3109/08916930108995998
2000
Journal Article
Peripheral tolerance to human papillomavirus E7 oncoprotein occurs by cross-tolerization, is largely Th-2-independent, and is broken by dendritic cell immunization
Doan, Tracy, Herd, Karen A., Lambert, Paul F., Fernando, Germain J. P., Street, Michael D. and Tindle, Robert W. (2000). Peripheral tolerance to human papillomavirus E7 oncoprotein occurs by cross-tolerization, is largely Th-2-independent, and is broken by dendritic cell immunization. Cancer Research, 60 (11), 2810-2815.
1999
Journal Article
Capture ELISA and in vitro cell binding assay for the detection of antibodies to human papillomavirus type 6b virus-like particles in patients with anogenital warts
Peng, Shiwen, Qi, Yingmei, Christensen, Neil, Hengst, Kylie, Kennedy, Lynn, Frazer, Ian H. and Tindle, Robert W. (1999). Capture ELISA and in vitro cell binding assay for the detection of antibodies to human papillomavirus type 6b virus-like particles in patients with anogenital warts. Pathology, 31 (4), 418-422. doi: 10.1080/003130299104846
1999
Journal Article
Human papillomavirus type 16 E7 oncoprotein expressed in peripheral epithelium tolerizes E7-directed cytotoxic T-lymphocyte precursors restricted through human (and mouse) major histocompatibility complex class I alleles
Doan, Tracy, Herd, Karen, Street, Michael, Bryson, Gregory, Fernando, Germain, Lambert, Paul and Tindle, Robert (1999). Human papillomavirus type 16 E7 oncoprotein expressed in peripheral epithelium tolerizes E7-directed cytotoxic T-lymphocyte precursors restricted through human (and mouse) major histocompatibility complex class I alleles. Journal of Virology, 73 (7), 6166-6170. doi: 10.1128/jvi.73.7.6166-6170.1999
1999
Journal Article
Differences in the effectiveness of delivery of B- and CTL-epitopes incorporated into the Hepatitis B core antigen (HBcAg) c/e1-region
Street, M., Herd, K., Londono, P., Doan, T., Dougan, G., Kast, W. M. and Tindle, R. W. (1999). Differences in the effectiveness of delivery of B- and CTL-epitopes incorporated into the Hepatitis B core antigen (HBcAg) c/e1-region. Archives of Virology, 144 (7), 1323-1343. doi: 10.1007/s007050050590
1999
Journal Article
Potential strategies utilised by papillomavirus to evade host immunity
Frazer, Ian H., Thomas, Ranjeny, Zhou, Jian A., Leggatt, Graham R., Dunn, Linda, Mcmillan, Nigel A. J., Tindle, Robert W., Filgueira, Luis, Manders, Peter, Barnard, Paula and Sharkey, Michael (1999). Potential strategies utilised by papillomavirus to evade host immunity. Immunological Reviews, 168 (1), 131-142. doi: 10.1111/j.1600-065X.1999.tb01288.x
1999
Book
Vaccines for Human Papillomavirus Infection and Anogenital Disease
Vaccines for Human Papillomavirus Infection and Anogenital Disease. Edited by Tindle, R. W. Richmond, TX United States: R. G. Landes Company, 1999.
1999
Book Chapter
Immunomodulation of HPV infection and disease
Tindle, R. W. (1999). Immunomodulation of HPV infection and disease. Vaccines for Human Papillomavirus Infection and Anogenital Disease. (pp. 1-12) edited by Robert W. Tindle. Texas, USA: R. G. Landes Company.
Funding
Supervision
Availability
- Emeritus Professor Robert Tindle is:
- Available for supervision
Before you email them, read our advice on how to contact a supervisor.
Supervision history
Completed supervision
-
2010
Doctor Philosophy
Hepatitis B Surface Antigen-based Vaccines for Human Neoplastic Disease
Principal Advisor
-
2007
Doctor Philosophy
THE USE OF HEPATITIS B SURFACE ANTIGEN-SMALL AS A VACCINE SYSTEM FOR DELIVERY OF FOREIGN CTL EPITOPES
Principal Advisor
Media
Enquiries
Contact Emeritus Professor Robert Tindle directly for media enquiries about:
- Human papillomavirus
- Human respiratory viruses
- Immune system and disease
- Immunisation
- Immunology
- Papillomavirus
- Respiratory viruses
- T-cells
- Vaccines
- Viral immunology
- Virology
- Viruses
Need help?
For help with finding experts, story ideas and media enquiries, contact our Media team: